Clinical Trials
7 trialsNCT03992664 2025-02-13
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
Cyprus University of Technology
Phase NA Completed
NCT04878692 2021-05-07
OPERA
Hospices Civils de Lyon
Phase NA Unknown
NCT03440515 2020-01-07
Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor
Asan Medical Center
Phase 2 Completed
NCT01931150 2017-01-13
Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT01315990 2013-12-18
DERMATUX
Johannes Gutenberg University Mainz
Phase 4 Unknown
NCT01466504 2013-04-15
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Dartmouth-Hitchcock Medical Center
Terminated
NCT01380262 2011-06-27
STLDD-1
Maria Sklodowska-Curie National Research Institute of Oncology
Unknown